When IL-17 inhibitors fail: real-life evidence to switch from secukinumab to adalimumab or ustekinumab

Giovanni Damiani, Rosalynn Rz Conic, Valerio de Vita, Antonio Costanzo, Roberto Regazzini, Paolo Dm Pigatto, Nicola L Bragazzi, Alessia Pacifico, Piergiorgio Malagoli

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'When IL-17 inhibitors fail: real-life evidence to switch from secukinumab to adalimumab or ustekinumab'. Together they form a unique fingerprint.

Medicine & Life Sciences